Allergies
Stallergenes' Immunotherapy Tablet Containing Recombinant Birch Pollen Allergen
Filed in archive Allergy Medications , Allergy: Research and Development , Hay Fever by ruth on September 25, 2009
Stallergenes' Immunotherapy Tablet Containing Recombinant Birch Pollen Allergen
© MiikaS
Stallergenes has announced positive results on a new phase IIb/III clinical trial on the efficacy of a sublingual immunotherapy tablet containing the recombinant allergen of this birch pollen, rBet v 1 in allergic rhinitis caused by this pollen. This study is the first ever to use a recombinant allergen as an active substance and possibly also the first in the world to use a recombinant protein in dry form.
The 3 treated groups demonstrated a statistically significant reduction in AASS in comparison with placebo (0.002



Permalink: Stallergenes' Immunotherapy Tablet Containing Recombinant Birch Pollen Allergen
Tags: immunotherapy  pollen+allergy  hay+fever  hayfever  birch+allergies  genetics  allergy  birch+pollen 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/162252
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Stallergenes' Immunotherapy Tablet Containing Recombinant Birch Pollen Allergen :

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 1 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!